BR0312004A - Composições de aerossol transdérmicas - Google Patents
Composições de aerossol transdérmicasInfo
- Publication number
- BR0312004A BR0312004A BR0312004-0A BR0312004A BR0312004A BR 0312004 A BR0312004 A BR 0312004A BR 0312004 A BR0312004 A BR 0312004A BR 0312004 A BR0312004 A BR 0312004A
- Authority
- BR
- Brazil
- Prior art keywords
- aerosol compositions
- transdermal
- active agents
- physiologically active
- penetration enhancers
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 abstract 2
- 239000003623 enhancer Substances 0.000 abstract 2
- 231100000223 dermal penetration Toxicity 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000003380 propellant Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000003981 vehicle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS3171A AUPS317102A0 (en) | 2002-06-25 | 2002-06-25 | Transdermal aerosol compositions |
| PCT/AU2003/000784 WO2004000275A1 (en) | 2002-06-25 | 2003-06-24 | Transdermal aerosol compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0312004A true BR0312004A (pt) | 2005-03-29 |
Family
ID=3836730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0312004-0A BR0312004A (pt) | 2002-06-25 | 2003-06-24 | Composições de aerossol transdérmicas |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1534241A1 (https=) |
| JP (1) | JP2005533795A (https=) |
| KR (1) | KR20050071373A (https=) |
| AU (1) | AUPS317102A0 (https=) |
| BR (1) | BR0312004A (https=) |
| CA (1) | CA2490325A1 (https=) |
| EA (1) | EA007351B1 (https=) |
| NZ (1) | NZ537435A (https=) |
| WO (1) | WO2004000275A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20050045946A (ko) * | 2002-06-25 | 2005-05-17 | 애크럭스 디디에스 피티와이 리미티드 | 비정질 약학적 조성물을 이용한 경피전달속도의 제어 |
| JP2007511544A (ja) * | 2003-11-19 | 2007-05-10 | アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド | アミロイド症の予防若しくは治療のための組成物および方法 |
| US20060263421A1 (en) | 2005-05-18 | 2006-11-23 | Abeille Pharmaceuticals Inc | Transdermal Method and Patch for Nausea |
| ES2494853T3 (es) * | 2007-11-02 | 2014-09-16 | Acrux Dds Pty Ltd | Sistema de administración transdérmica |
| US20120322828A1 (en) * | 2011-02-15 | 2012-12-20 | Eli Lilly And Company | Methods for controlling pain in equines using a transdermal solution of fentanyl |
| EA201391023A1 (ru) * | 2011-02-15 | 2014-01-30 | Эли Лилли Энд Компани | Способ снижения боли у животных семейства собачьих с помощью трансдермального раствора фентанила |
| US12459965B2 (en) | 2017-10-09 | 2025-11-04 | Compass Pathfinder Limited | Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| KR20220009954A (ko) | 2019-04-17 | 2022-01-25 | 컴퍼스 패쓰파인더 리미티드 | 신경인지 장애, 만성 통증을 치료하고 염증을 감소시키는 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5082866A (en) * | 1988-06-01 | 1992-01-21 | Odontex, Inc. | Biodegradable absorption enhancers |
| AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
| US6004969A (en) * | 1996-04-15 | 1999-12-21 | National Science Council | Transdermal delivery of buprenorphine preparations |
| NZ513208A (en) * | 1999-02-05 | 2003-05-30 | Cipla Ltd | Topical sprays comprising a film forming composition |
| IN191090B (https=) * | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd |
-
2002
- 2002-06-25 AU AUPS3171A patent/AUPS317102A0/en not_active Abandoned
-
2003
- 2003-06-24 NZ NZ537435A patent/NZ537435A/en unknown
- 2003-06-24 WO PCT/AU2003/000784 patent/WO2004000275A1/en not_active Ceased
- 2003-06-24 CA CA002490325A patent/CA2490325A1/en not_active Abandoned
- 2003-06-24 EP EP03732114A patent/EP1534241A1/en not_active Withdrawn
- 2003-06-24 JP JP2004514437A patent/JP2005533795A/ja not_active Withdrawn
- 2003-06-24 EA EA200500082A patent/EA007351B1/ru not_active IP Right Cessation
- 2003-06-24 KR KR1020047020967A patent/KR20050071373A/ko not_active Ceased
- 2003-06-24 BR BR0312004-0A patent/BR0312004A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2005533795A (ja) | 2005-11-10 |
| KR20050071373A (ko) | 2005-07-07 |
| NZ537435A (en) | 2006-02-24 |
| CA2490325A1 (en) | 2003-12-31 |
| AUPS317102A0 (en) | 2002-07-18 |
| WO2004000275A1 (en) | 2003-12-31 |
| EP1534241A1 (en) | 2005-06-01 |
| EA200500082A1 (ru) | 2005-06-30 |
| EA007351B1 (ru) | 2006-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2602450T3 (es) | Composición farmacéutica para uso dérmico para el tratamiento de la psoriasis que comprende calcipotril y betametasona | |
| BR0313343A (pt) | Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal | |
| EA200500084A1 (ru) | Фармацевтическая композиция для чрескожной доставки активного агента | |
| ATE471144T1 (de) | Intranasale verabreichung von schnell wirkendem insulin | |
| BR0317876A (pt) | Composições de liberação de droga tópica estáveis | |
| WO2008108286A1 (ja) | 経皮吸収医薬組成物、医薬組成物貯蔵ユニットおよびこれを利用する経皮吸収製剤 | |
| WO2002015903A3 (de) | Neue pharmazeutische zusammensetzung zur verabreichung von n-0923 | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| AR046878A1 (es) | Agente endoparasiticida para administracion topica | |
| BR9810729B1 (pt) | composição farmacêutica para compostos lipofìlicos ácidos disposta como uma formulação auto-emulsificante. | |
| KR20010042626A (ko) | 활성 성분의 흡수 강화를 위한 활성을 갖는 화합물을함유하는 약학적 조성물 | |
| EA200601724A1 (ru) | Новые композиции для местной доставки | |
| CY1105931T1 (el) | Χρηση ενος αγωνιστη/ανταγωνιστη οιστρογονου για την αντιμετωπιση γυναικειας σεξουαλικης δυσλειτουργιας | |
| ATE356612T1 (de) | Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit | |
| WO2007117581A3 (en) | Stabilized transdermal bupropion preparations | |
| KR970706021A (ko) | N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS) | |
| NO20062051L (no) | Farmasoytisk virkestoffinneholdende formulering med belegg | |
| BR0312004A (pt) | Composições de aerossol transdérmicas | |
| DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
| BRPI0415725A (pt) | formulação aspergìvel transdérmica, método para administrar um agente farmaceuticamente ativo e método para formar uma pelìcula farmaceuticamente ativa | |
| BR0108313A (pt) | Composição farmacêutica para injeção intramuscular contendo loxoprofeno | |
| DK1300143T3 (da) | Plaster som indeholder 4-biphenyleddikesyre | |
| BRPI0506496A (pt) | conservantes antimicrobianos para obtenção de formulação de multidose usando beta-ciclodextrinas para formas de dosagem lìquidas | |
| KR910021238A (ko) | 켈로이드 치료제 | |
| WO2006091719A3 (en) | Compositions and methods enhancing transdermal delivery of drugs and biologics |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2116 DE 26/07/2011. |